This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Janssen Pharmaceutica Nv. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations by Inventor Jimmy Nguyen
Introduction
Jimmy Nguyen is an accomplished inventor based in Fremont, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable formulations. His innovative work focuses on improving the resuspendability of paliperidone palmitate, a medication used to treat schizophrenia.
Latest Patents
Jimmy Nguyen holds a patent for "Methods for ensuring resuspension of paliperidone palmitate formulations." This patent outlines methods aimed at enhancing the resuspendability of a paliperidone palmitate extended-release injectable suspension within a syringe. The invention reduces the force required for injection and minimizes the likelihood of incomplete injection. It emphasizes maintaining the syringe in a specific orientation during shipping, which differs from its orientation during pre-shipping storage. The patent also describes populations of syringes containing the injectable suspension, ensuring they are shipped in the desired orientation.
Career Highlights
Jimmy Nguyen is currently employed at Janssen Pharmaceutica NV, where he continues to innovate in the pharmaceutical industry. His work has been instrumental in advancing the delivery methods of critical medications, thereby improving patient outcomes.
Collaborations
Some of his notable coworkers include Peter D'Hoore and Ignace Wallaert, who contribute to the collaborative environment at Janssen Pharmaceutica NV.
Conclusion
Jimmy Nguyen's innovative contributions to the field of pharmaceuticals, particularly through his patent on paliperidone palmitate formulations, highlight his commitment to improving medication delivery systems. His work continues to have a positive impact on the treatment of schizophrenia.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
